标题
Safety of FLT3 inhibitors in patients with acute myeloid leukemia
作者
关键词
-
出版物
Expert Review of Hematology
Volume 14, Issue 9, Pages 851-865
出版商
Informa UK Limited
发表日期
2021-08-23
DOI
10.1080/17474086.2021.1969911
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The safety profile of FLT3 inhibitors in the treatment of newly diagnosed or relapsed/refractory acute myeloid leukemia
- (2021) Giovanni Marconi et al. Expert Opinion On Drug Safety
- IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
- (2021) Claudio Cerchione et al. Frontiers in Oncology
- Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling
- (2021) Adrián Mosquera Orgueira et al. Frontiers in Oncology
- Immunotherapy in Acute Myeloid Leukemia: Where We Stand
- (2021) Alessandro Isidori et al. Frontiers in Oncology
- A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT)
- (2020) Anat Stern et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
- (2020) Jannik Stemler et al. ANNALS OF HEMATOLOGY
- Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial
- (2020) Li Xuan et al. LANCET ONCOLOGY
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
- (2019) Hyunkyung Park et al. BMC CANCER
- Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients
- (2019) Lauren Fontana et al. CLINICAL INFECTIOUS DISEASES
- Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
- (2019) Jorge E Cortes et al. LANCET ONCOLOGY
- Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia
- (2019) Taylor M. Weis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Epidemiological aspects and characterization of the resistance profile of Fusarium spp. in patients with invasive fusariosis
- (2019) Priscila Dallé da Rosa et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Phase II Randomized Trial of Gilteritinib Vs Midostaurin in Newly Diagnosed FLT3 Mutated Acute Myeloid Leukemia (AML)
- (2019) Selina M. Luger et al. BLOOD
- Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia
- (2019) Brian T. Fisher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Midostaurin and cyclosporine drug interaction: A case report
- (2019) Robert Mancini et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML
- (2019) Alexander E. Perl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Azole antifungals and new targeted therapies for hematological malignancy
- (2019) Julian Lindsay et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Bridging antifungal prophylaxis with 50 mg or 100 mg micafungin in allogeneic stem cell transplantation: A retrospective analysis
- (2019) Achim Rothe et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Sorafenib Combined with 5-azacytidine (AZA) in Older Patients with Untreated FLT3 -ITD Mutated Acute Myeloid Leukemia (AML)
- (2018) Maro Ohanian et al. AMERICAN JOURNAL OF HEMATOLOGY
- Phase 2b study of two dosing regimens of quizartinib monotherapy in FLT3-ITD mutated, relapsed or refractory AML
- (2018) Jorge E. Cortes et al. BLOOD
- Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting?
- (2018) Monica Fung et al. CLINICAL INFECTIOUS DISEASES
- Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 Relationship
- (2018) Tao Liu et al. CTS-Clinical and Translational Science
- Hematopoietic stem cell transplantation for acute myeloid leukemia
- (2018) Akiyoshi Takami INTERNATIONAL JOURNAL OF HEMATOLOGY
- Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
- (2018) Courtney D DiNardo et al. LANCET ONCOLOGY
- Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
- (2018) Richard F. Schlenk et al. BLOOD
- Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
- (2017) S.K. Metzelder et al. EUROPEAN JOURNAL OF CANCER
- FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions
- (2017) Maria Larrosa-Garcia et al. MOLECULAR CANCER THERAPEUTICS
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
- (2017) Richard M. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Haematopoietic cell transplantation with and without sorafenib maintenance for patients withFLT3-ITD acute myeloid leukaemia in first complete remission
- (2016) Andrew M. Brunner et al. BRITISH JOURNAL OF HAEMATOLOGY
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study
- (2015) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia
- (2015) I-K Park et al. LEUKEMIA
- Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic target
- (2013) I.-K. Park et al. BLOOD
- Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants
- (2013) A. Galanis et al. BLOOD
- Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation
- (2013) F. Ravandi et al. BLOOD
- Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial
- (2013) Hubert Serve et al. JOURNAL OF CLINICAL ONCOLOGY
- Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML
- (2012) A. Sexauer et al. BLOOD
- Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
- (2011) C. Schmid et al. BLOOD
- Toxicity of sorafenib: clinical and molecular aspects
- (2010) Benoit Blanchet et al. Expert Opinion On Drug Safety
- Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia
- (2010) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy
- (2009) Francesco Torino et al. Nature Reviews Clinical Oncology
- Anthracycline Dose Intensification in Acute Myeloid Leukemia
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Acquired copy number alterations in adult acute myeloid leukemia genomes
- (2009) M. J. Walter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
- (2009) Gloria N. Mattiuzzi et al. SUPPORTIVE CARE IN CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More